New Triple-Drug attack targets Hard-to-Treat colorectal cancer in the liver
Disease control
Not yet recruiting
This study tests whether a combination of three drugs—balstilimab, botensilimab, and agenT-797—can shrink tumors in adults with a specific type of advanced colorectal cancer that has spread to the liver and has not responded to prior treatments. All 17 participants will receive t…
Phase: PHASE2 • Sponsor: Darren Sigal, MD • Aim: Disease control
Last updated May 07, 2026 10:34 UTC